Purchase Order HT941025P0036
Award Date
1/28/25
Potential Completion Date
2/8/28
Potential Value
$68K
Federal Agency
Defense Health Agency
Awardee
Cerus Corporation
Ultimate Awardee
Not listed
PSC Category
J065 - Maint/Repair/Rebuild Of Equipment- Medical, Dental, And Veterinary Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Japan
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Cerus Corporation, a biomedical products company specializing in blood safety technologies. The contract is for the service and maintenance of the Cerus INTERCEPT Illuminator, which is a key component of the company's proprietary INTERCEPT Blood System. The INTERCEPT system uses riboflavin and ultraviolet light to inactivate pathogens in blood components, including platelets, plasma, and red blood cells,...
This firm fixed price purchase order was awarded by the Defense Health Agency to Cerus Corporation for annual preventative maintenance of Intercept Illuminators located at Portsmouth, Virginia. Valued at $66,388, the contract includes a base year and four option years of maintenance and support for illuminators used to treat blood products. The sole source justification indicates the equipment requires specialized maintenance that can only be performed by the original equipment manufacturer....
The Defense Health Agency (DHA) awarded a firm-fixed-price contract to Cerus Corporation for the purchase of INTERCEPT Platelet Small Volume Sets (INT 2140B) and INTERCEPT Dual Storage Processing Sets (INT2540B) to support the U.S. Pacific Command Armed Services Blood Bank Center (USPACOM ASBBC) at the U.S. Naval Hospital Okinawa, Japan. The contract, valued at $106,824.00 with a potential period of performance through September 1, 2027, was awarded on a sole-source basis as Cerus Corporation is...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Cerus Corporation, a biomedical products company specializing in blood safety technologies and pathogen reduction systems. The contract is for the INTERCEPT Platelet Processing Set and service maintenance, with a ceiling value of $193,882.00 and a period of performance from January 14, 2025 to September 30, 2027. The contract stems from a sole-source solicitation for the INTERCEPT Blood System...
This firm fixed-price purchase order contract was awarded by the Defense Health Agency (DHA) to Cerus Corporation, a biomedical products company specializing in blood safety technologies and pathogen reduction systems. The $369,384 contract is for the provision of Cerus' proprietary INTERCEPT Blood System, which uses riboflavin and ultraviolet light to inactivate pathogens in blood components, including platelets and plasma. This pathogen reduction technology plays a critical role in reducing...
The Defense Health Agency awarded a Firm Fixed Price, $186,048.00 purchase order contract to Cerus Corporation, a biomedical products manufacturer, for the drop shipment of medical supplies. The contract is sole source and not set aside. The supplies include the INTERCEPT Blood System technology, which uses riboflavin and UV light to inactivate pathogens in blood platelets and plasma. Cerus has received over 20 federal contract awards since 2002 from agencies such as the Department of Defense,...
This contract was awarded by the Defense Health Agency (DHA) to Cerus Corporation, a biomedical products company specializing in blood safety technologies and pathogen reduction systems. The contract is for the procurement of Cerus Intercept Platelet Pathogen Reduction Sets, which use a chemical agent and ultraviolet light to inactivate pathogens in blood products, primarily platelets and plasma. The contract is a firm-fixed-price purchase order with a ceiling value of $258,240.00 and a period...
This is a $133,640.00 firm fixed price purchase order awarded by the Defense Health Agency to Cerus Corporation, a small business manufacturer of biomedical products. The contract is for the provision of illuminator equipment and related maintenance services, with a completion date of October 24, 2019. Cerus has received over 20 previous federal contracts from agencies including the Department of Defense, Department of Veterans Affairs, and Department of Health and Human Services to provide...
This federal contract award was issued by the Bureau of Medicine and Surgery, a defense agency, to Cerus Corporation, a biomedical products company specializing in blood safety technologies. The $138,800 firm-fixed-price contract is for the supply of INTERCEPT Illuminator 60 Hz equipment and INTERCEPT Platelet Processing Sets with Dual Storage, as well as related services, to support the agency's blood product safety requirements. Cerus Corporation's proprietary INTERCEPT Blood System uses...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Cerus Corporation, a biomedical products company specializing in blood safety technologies. The contract, valued at $146,200.00, is for the procurement of INTERCEPT Blood System processing sets for dual storage. The INTERCEPT system uses riboflavin and ultraviolet light to inactivate pathogens in blood components such as platelets and plasma, enhancing blood safety. Cerus has a history of supplying its...